SJ-3366, a Unique and Highly Potent Nonnucleoside Reverse Transcriptase Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1) That Also Inhibits HIV-2

Robert W. Buckheit(Ionis Pharmaceuticals (United States)), E.-H. Cho(Samjin Pharm (South Korea)), J.-W. Lee(Samjin Pharm (South Korea)), Mark C. Osterling(Southern Research Institute), S.-H. Lee(Samjin Pharm (South Korea)), Karen Watson(Southern Research Institute), Valerie Fliakas-Boltz(Southern Research Institute), Jong‐Won Oh(Yonsei University), E. Lucile White(Southern Research Institute), Luke A. Pallansch(Southern Research Institute), Ho Seok Kwon(Samjin Pharm (South Korea)), Julie Russell(Southern Research Institute), Sun Gan Chung(Samjin Pharm (South Korea)), Jim A. Turpin(Southern Research Institute), Tracy L. Loftus(Southern Research Institute)
Antimicrobial Agents and Chemotherapy
February 1, 2001
Cited by 77


Related Papers